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Role of Amoxicillin Serum Levels for Successful Prophylaxis of Experimental
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The importance of amoxicillin serum profiles for successful prophylaxis ofexperimental endo-
carditis in rats was assessed. Animals with catheter-induced vegetations were challenged intrave-
nously with large inocula of Streptococcus sanguisand received one of the following amoxicillin
dosages: single or multiple bolus injection of 40 rug/kg; 40 mg/kg administered as a continuous
infusion over 12 h; or either 9 or 18 rug/kg administered over 12 or 24 h, respectively. The
regimen producing a single transient high peak serum level failed to prevent experimental endo-
carditis; in contrast, a second injection 6 h after the first resulted in successful prophylaxis.
Likewise, the three regimens of continuous, relatively low-dose regimens prevented infections.
Thus, the most important parameter for successful prophylaxis was the duration of inhibitory
concentration of the drug in the serum, The total dose of antibiotic, the peak serum levels, or the
area-under-the-curve values were not predictive of successful prophylaxis.
To prevent streptococcal endocarditis in patients undergo-
ing medical or surgical procedures that put them at risk for
bacteremia, high and sometimes repeated doses ofantibiotics
are recommended [1,2]. This strategy has been largely based
on results of animal studies showing that high and prolonged
levels of bactericidal antibiotics (given before or shortly after
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intravenous [iv] bacterial challenge) were necessary to pro-
vide optimal protection against streptococcal endocarditis in
rabbits and rats [3, 4].
However, while experimental evidence has demonstrated
that prolonged antibiotic serum levels were more effective
than short-course prophylaxis [3], the importance of drug
serum levels per se for successful protection has not been
thoroughly investigated. In fact, while large doses of antibi-
otics are recommended for prophylaxis, several lines of evi-
dence suggest that high drug concentrations might not be a
prerequisite for successful protection. First, many antibiotics
do not gain efficacy in a dose-dependent manner once above
the MIC. For example, the optimal bactericidal concentra-
tion of penicillins in vitro (the most frequently recom-
mended drugs for prophylaxis) is usually not much higher
than their MICs [5]. Moreover, paradoxically low bacterial
killinghas been described at high concentrations ofsuch anti-
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biotics [6]. Second, studies have shown that multiple doses of
penicillin V, which produced prolonged but relatively low
serum levels of antibiotic, successfully prevented endocardi-
tis in rabbits challenged with large bacterial inocula (i.e., 108
cfu) [7]. Therefore, the high blood concentrations of antibi-
otics resulting from most prophylactic regimens in humans
may not be required for successful protection but merely en-
sure more prolonged serum levels.
In the present experiments, we investigated the impor-
tance of serum levels of amoxicillin for successful prophy-
laxis of experimental endocarditis in rats challenged with a
large inoculum of Streptococcus sanguis.
Materials and Methods
Bacterial strain and antibiotic susceptibility. A previously
described strain of Streptococcus sanguis was used [8]. The MIC
and MBC values of amoxicillin for this strain were 0.032 mg/L
and> 128 rng/L, respectively. Thus, the test organism was "tol-
erant" to amoxicillin as defined by an MBC to MlC ratio >32
and by an ability to survive amoxicillin treatment in time-kill
curves in vitro [8].
Serum inhibitory and bactericidal titers. Serum inhibitory
and bactericidal titers of amoxicillin were measured as previ-
ously described [3] in groups of 9 rats, either after a single iv
bolus of 40 mg/kg amoxicillin (at 30 min and 2 and 6 h) or after
continuous infusion of the drug (at 1, 3, 6, 8, 12, and 14 h).
Organisms were subcultured on penicillinase-containing blood
agar (5 X 106 IU/L; Bactopcnase; Difco, Detroit). The serum
inhibitory titer was the highest dilution of serum inhibiting visi-
ble bacterial growth, and the serum bactericidal titer was the
highest dilution ofserum providing 99.9% killing of the original
inoculum after incubation for 18 h.
Serum levelsofamoxicillin. Serum levels ofamoxicillin were
determined in groups of 3-6 rats several times during and after
antibiotic administration. Antibiotic concentrations were mea-
sured by the agar diffusion method using Bacillus subtilis ATCC
6633 [9]. For standard curves, amoxicillin was diluted in pooled
rat serum. The limit of detection of the bioassay was 0.6 mg/L.
Production of endocarditis and installation of the infusion-
pump device. Female Wistar rats (180-200 g) were used. As
previously described [3, 8], a polyethylene catheter was placed
through the right carotid artery across the aortic valve and se-
cured with a silk ligature. At the same time, a sterile silastic
catheter (Dow Chemical, Midland, MI) was inserted through
the jugular vein into the superior vena cava. The line was tun-
neled subcutaneously and brought to the skin of the interscapu-
lar region. The external portion of this cannula was connected
to a programmable infusion pump (pump 44; Harvard Appara-
tus. South Natick, MA) through a flow-through swivel, which
permitted the animal to move in the cage [10]. Bacterial endo-
carditis was induced 24 h after catheterization by iv challenge
with various sizes of bacterial inocula.
Efficacy of various doses ofamoxicillin administered either as
an iv bolus or continuous infusion. Rats were challenged with
--100 times the 1090 of S. sanguis (10 7- 8 cfu). To ensure that
infected rats were exposed to a precise amount of drug, antibi-
otic prophylaxis was started immediately after iv bacterial chal-
lenge. Despite the fact that this setting does not exactly mimic
antibiotic prophylaxis in humans (who are given prophylaxis
prior to procedures that could cause bacteremia), such postchal-
lenge prophylaxis has proved to be as effective as standard pre-
challenge administration of amoxicillin in experimental endo-
carditis [II]. Moreover, there is ample evidence in both animals
and humans to suggest that prophylactic antibiotics operate es-
sentially after, not before, transient bacteremia induced by pro-
cedures such as dental extractions (in animals and humans [12])
or after iv bacterial challenge (in animals [3]). We used the fol-
lowing amoxicillin regimens: single or multiple bolus injection
of 40 mg/kg, a total of 40 mg/kg slowly infused over 12 h (by
infusion pump), 9 mg/kg administered by continuous infusion
over 12 h, and 18 mg/kg administered over 24 h. Controls re-
ceived saline.
Evaluation of prophylaxis. Animals were killed 48-72 h
after bacterial challenge. Aortic vegetations were excised,
weighed, homogenized in I mL of saline, serially diluted, and
plated on penicillinase-containing blood agar plates. The num-
ber of viable bacteria was counted after 48 h of incubation at
3re, and the results were expressed in 10gIO cfu/gof vegetation.
The dilution technique permitted the detection of'> 102 cfu/g of
vegetation.
Pharmacokinetic parameters and statistical analysis. The
area-under-the-curve (AUC) values were calculated by the log
trapezoid method [13]. The x2 test with Yates's correction was
used for statistical comparison.
Results
Efficacy ofa fixed dose ofamoxicillin administered either as
an iv bolus or continuous infusion. To delineate which pa-
rameters were important in preventing endocarditis, experi-
ments were designed to analyze the role of the peak serum
level, the total dose of antibiotic, the AVC values of antibi-
otic serum levels, and the duration of inhibitory drug serum
levels after bacterial challenge. The serum kinetics produced
by the various antibiotic regimens (figure IA) and the result-
ing serum inhibitory titers (figure IB) are shown. A single
bolus injection of 40 mg/kg amoxicillin (curve a) generated
high peak serum levels (75 mg/L) that were ~2000 times the
MIC of amoxicillin for S. sanguis and high AVC values (60
mg/L . h) but a relatively short duration in serum ofthe drug
(~6 h), as shown by serum drug levels and inhibitory titers.
Of note, no serum bactericidal titers were detected at any
time. In comparison, continuous infusion (curve b) pro-
duced substantially lower drug serum levels (3 mg/L) and
Ave values (20 mg/L • h) but longer duration in serum of
the drug (;?; 12 h).
In vivo, these two regimens showed different efficacies.
Figure 2 shows that iv bolus (column a) did not protect rats
challenged with 100 times the ID go ofS. sanguis. In contrast,
however, 12 h of continuous infusion protected rats chal-
lenged with the large inoculum (column b) even though it
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Figure 2. Prophylaxis of experimental endocarditis with amoxi-
cillin given as intravenous (iv) bolus or prolonged (12 or 24 h)
infusion. Rats were challenged with -100 times the ID90 ofStrep-
tococcus sanguis. Prophylaxis was started immediately after chal-
lenge. Treatment groups received a, iv bolus, 40 mg ofamoxicillin/
kg; b, continuous 12-h infusion of 40 rug/kg; c, continuous 12-h
infusion of 9 mg/kg: d, continuous 24-h infusion of 18 mg/kg; and
e, 2 consecutive iv bolus infections of 40 rng/kg at 6-h intervals.
Number of animals per group are indicated at bottom of columns.
*p < .05 compared with animals injected with saline or single bolus
of antibiotic (a).
These results demonstrate that the most important feature
underlying successful amoxicillin prophylaxis against toler-
ant streptococcal endocarditis was the duration of antibiotic
serum inhibitory titers after bacterial challenge. Successful
prophylaxis against this organism did not require high peak
serum levels of antibiotics, as often advocated for antibiotic
prophylaxis against endocarditis in humans [I, 2]. Indeed, in
our experiments, high peak serum levels produced by a sin-
gle iv bolus of 40 mg/kg amoxicillin (as often used in antibi-
otic prophylaxis experiments [3, 8]) failed to prevent endo-
carditis due to large bacterial inocula, despite peak serum
concentrations of antibiotics that were ~2000 times greater
than the MIC for the test organism and of serum inhibitory
titers that were detectable for almost 6 h. In contrast, drug
serum levels that were 20 times lower maintained by continu-
ous injection for ~ 12 h effectively protected the animals de-
spite AVC values that were 60 times lower than after the iv
bolus regimen. Thus, the only relevant parameter that reli-
ably predicted successful prophylaxis was the duration of
serum inhibitory activity after bacterial challenge. The total
antibiotic dose, peak serum levels, or AVC values did not
correlate with protection of the animals.
In these experiments, antibiotic serum levels producing
inhibitory titers as low as Ys successfully prevented experi-
mental endocarditis. Whether even lower levels would also
be protective is not known. However, no serum bactericidal
activity was detected against this tolerant streptococcal strain
at any time or at any antibiotic dosage. Thus, successful pro-
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Bacterial challenge
produced substantially lower drug levels and AVC values
than did iv bolus. Thus, in this setting, the total dose of
antibiotic, the peak serum levels, or AVC values were not
predictive ofsuccessful prophylaxis. The most important pa-
rameter appeared to be the duration of detectable antibiotic
serum levels after bacterial challenge. To test whether these
observations might be confirmed under more stringent con-
ditions, additional experiments were done using a dose of
amoxicillin that was two to four times lower.
Prophylaxis with prolonged low-dose amoxicillin. Com-
pared with the iv bolus regimen (figure l, curve a), infusion
of 9 mg/kg amoxicillin over 12 h (curve c) or 18 mg/kg over
24 h (curve d) produced serum levels that were> 100 times
lower (0.6 vs. 75 rng/L compared with iv bolus) and AVC
values that were 5-10 times lower (6-12 vs. 60 mg/L . h)
but substantially longer detectable serum drug levels and in-
hibitory titers. As a result, prophylaxis with both low-dose
regimens successfully prevented endocarditis in rats chal-
lenged with 100 times the 1090 of S. sanguis (figure 2, col-
umns c and d) whereas iv bolus did not (column a).
Efficacy of a single bolus of amoxicillin versus two doses
injected at a 6-h interval. Since a single bolus injection of
amoxicillin produced only a transient drug level in serum of
~6 h, we tested whether prolonging this drug level by a sec-
ond dose of 40 mg/kg antibiotic given 6 h later might restore
successful prophylaxis. As expected, injection of this second
dose restored successful prophylaxis (figure 2, column e).
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Figure 1. Amoxicillin serum levels (A) and serum inhibitory
titers (B) produced by various antibiotic regimens in rats: a, single
bolus injection, 40 mg/kg: b, continuous infusion of40 rng/kg over
12 h: c, continuous infusion of9 mg/kg over 12 h; and d, continu-
ous infusion of 18 mg/kg over 24 h. No serum bactericidal titers
were detected at any time or at any dosage.
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phylaxis was unlikely to be mediated by mere antibiotic-in-
duced killing. In such nonkilling conditions, the exact mecha-
nism underlying successful prophylaxis remains speculative.
One hypothesis suggests that prolonged inhibition of bacte-
rial growth by nonkilling antibiotics may allow enough time
for alternative host defense mechanism(s), such as platelet
microbicidal protein(s) [14], to clear bacteria from the vegeta-
tions. If true, such mechanism(s) would be of major impor-
tance for prophylaxis, and presumably also therapy, ofendo-
carditis due to tolerant (and maybe also nontolerant)
streptococci. This may be particularly relevant because up to
80% of streptococci isolated from patients with endocarditis
may be tolerant to {j-lactam antibiotics and other cell wall
inhibitors [5]. Moreover, since prolonged low-dose prophy-
laxis protected animals challenged with a highly amoxicillin-
tolerant streptococcal strain, it is likely that such a regimen
would also protect rats inoculated with non tolerant (kill-sen-
sitive) streptococci.
Although the results of animal experiments cannot be ap-
plied directly to humans. the present observation bears some
practical implications. First, the results strongly support the
current recommendations of the American Heart Associa-
tion, which advocates two successive doses of amoxicillin (3
g and 1.5 g 6 h later) as oral prophylaxis for dental proce-
dures [1]. Such a regimen provides antibiotic coverage for
> 10 h, a period that appeared optimal in our setting. More-
over, administration of two consecutive doses of antibiotics
may also find some support in our results with repeated (two
dose) iv bolus regimen: Injection of a second iv bolus of
amoxicillin 6 h after the first restored successful prophylaxis,
presumably by prolonging the overall duration of serum in-
hibitory titers from ~6 h (after a single bolus) to -- 12 h.
Second, our observations raise the question of prolonged
low-dose prophylaxis for humans. Such a regimen might
avoid the side effects linked to high doses of oral antibiotics.
Prolonged low-dose prophylaxis may be particularly conve-
nient by using antibiotics with long serum half-lives in hu-
mans. However, a low-dose regimen in humans must be han-
dled with caution, because prophylaxis failure has been
described after prolonged courses of relatively low doses of
antibiotics without an initial loading dose [15]. Therefore,
further studies of prolonged low-dose prophylaxis are
warranted.
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